Top Markets
Coin of the day
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Rang in Aktien #33962
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Aktienkurs
$0.5813
Marktkapitalisierung
$6.50M
Veränderung (1 Tag)
-23.07%
Veränderung (1 Jahr)
-56.29%
Land
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategorie

Kursverlauf für Citius Pharmaceuticals, Inc. (CTXR)
Höchster Schlusskurs: $0.69 am 2026-08-01

Niedrigster Schlusskurs: $374.99 am 2014-10-01
Kursverlauf der Aktie von Citius Pharmaceuticals, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -13.63%
2025 -66.66%
2024 -83.96%
2023 -24.36%
2022 -35.96%
2021 48.68%
2020 66.19%
2019 -38.70%
2018 -76.18%
2017 -33.16%
2016 -74.07%
2015 50.02%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$513.82 30.81%
US
$991.94 51.71%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE